Amorphical Names Eden Ben as CEO to Advance Nano-Amorphous Mineral Therapeutics
HIMSS has announced the appointment of Harold “Hal” Wolf III as its new president and CEO. He will succeed…
As Cureatr enters a national-growth phase, new executive leadership rises to the challenge to strategically scale the business Cureatr, Inc. announced…